Bethanechol Chloride BETHANECHOL CHLORIDE UPSHER-SMITH LABORATORIES, LLC FDA Approved Bethanechol chloride, USP, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine. It is designated chemically as 2-[(aminocarbonyl)oxy]- N , N , N -trimethyl-1-propanaminium chloride. Its molecular formula is C 7 H 17 ClN 2 O 2 and its structural formula is: It is a white, hygroscopic crystalline powder having a slight amine-like odor, freely soluble in water, and has a molecular weight of 196.68. Each tablet for oral administration contains 5 mg, 10 mg, 25 mg or 50 mg bethanechol chloride, USP. Tablets also contain the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, (25 mg and 50 mg) D&C Yellow #10 Lake and FD&C Yellow #6 Lake. Structure formula

Drug Facts

Composition & Profile

Strengths
5 mg 00 unit 10 mg 25 mg 50 mg
Quantities
100 tablets
Treats Conditions
Indications And Usage Bethanechol Chloride Tablets Are Indicated For The Treatment Of Acute Postoperative And Postpartum Nonobstructive Functional Urinary Retention And For Neurogenic Atony Of The Urinary Bladder With Retention
Pill Appearance
Shape: round Color: white Imprint: BCL;50;832

Identifiers & Packaging

Container Type BOTTLE
UPC
0308320510002 0308320513003 0308320511009 0308320512006
UNII
H4QBZ2LO84
Packaging

HOW SUPPLIED Bethanechol Chloride Tablets, USP 5 mg tablets are white, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 5, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0510-00 Unit-dose cartons of 100 tablets NDC 0832-0510-01 10 mg tablets are white, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 10, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0511-00 Unit-dose cartons of 100 tablets NDC 0832-0511-01 25 mg tablets are yellow, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 25, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0512-00 Unit-dose cartons of 100 tablets NDC 0832-0512-01 50 mg tablets are yellow, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 50, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0513-00 Unit-dose cartons of 100 tablets NDC 0832-0513-01 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight container as defined in the USP. Keep out of reach of children. Distributed by UPSHER-SMITH LABORATORIES, LLC Maple Grove, MN 55369 Made in Taiwan Revised: 4/2025; PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label NDC 0832-0511-00 Bethanechol Chloride Tablets, USP 10 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 10 mg Tablets; PRINCIPAL DISPLAY PANEL - 5 mg Tablet Bottle Label NDC 0832-0510-00 Bethanechol Chloride Tablets, USP 5 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 5 mg Tablets; PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label NDC 0832-0512-00 Bethanechol Chloride Tablets, USP 25 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 25 mg Tablets; PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label NDC 0832-0513-00 Bethanechol Chloride Tablets, USP 50 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 50 mg Tablets

Package Descriptions
  • HOW SUPPLIED Bethanechol Chloride Tablets, USP 5 mg tablets are white, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 5, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0510-00 Unit-dose cartons of 100 tablets NDC 0832-0510-01 10 mg tablets are white, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 10, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0511-00 Unit-dose cartons of 100 tablets NDC 0832-0511-01 25 mg tablets are yellow, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 25, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0512-00 Unit-dose cartons of 100 tablets NDC 0832-0512-01 50 mg tablets are yellow, 7/16" diameter, round flat faced bevel edge tablets; one side scored and debossed BCL bisect 50, one side debossed 832. They are supplied as follows: Bottles of 100 tablets NDC 0832-0513-00 Unit-dose cartons of 100 tablets NDC 0832-0513-01 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight container as defined in the USP. Keep out of reach of children. Distributed by UPSHER-SMITH LABORATORIES, LLC Maple Grove, MN 55369 Made in Taiwan Revised: 4/2025
  • PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label NDC 0832-0511-00 Bethanechol Chloride Tablets, USP 10 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 10 mg Tablets
  • PRINCIPAL DISPLAY PANEL - 5 mg Tablet Bottle Label NDC 0832-0510-00 Bethanechol Chloride Tablets, USP 5 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 5 mg Tablets
  • PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label NDC 0832-0512-00 Bethanechol Chloride Tablets, USP 25 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 25 mg Tablets
  • PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label NDC 0832-0513-00 Bethanechol Chloride Tablets, USP 50 mg 100 Tablets Rx only UPSHER-SMITH Bethanechol 50 mg Tablets

Overview

Bethanechol chloride, USP, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine. It is designated chemically as 2-[(aminocarbonyl)oxy]- N , N , N -trimethyl-1-propanaminium chloride. Its molecular formula is C 7 H 17 ClN 2 O 2 and its structural formula is: It is a white, hygroscopic crystalline powder having a slight amine-like odor, freely soluble in water, and has a molecular weight of 196.68. Each tablet for oral administration contains 5 mg, 10 mg, 25 mg or 50 mg bethanechol chloride, USP. Tablets also contain the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, (25 mg and 50 mg) D&C Yellow #10 Lake and FD&C Yellow #6 Lake. Structure formula

Indications & Usage

Bethanechol chloride tablets are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.

Dosage & Administration

Dosage must be individualized, depending on the type and severity of the condition to be treated. Preferably give the drug when the stomach is empty. If taken soon after eating, nausea and vomiting may occur. The usual adult oral dose ranges from 10 to 50 mg three or four times a day. The minimum effective dose is determined by giving 5 to 10 mg initially and repeating the same amount at hourly intervals until satisfactory response occurs, or until a maximum of 50 mg has been given. The effects of the drug sometimes appear within 30 minutes and are usually maximal within 60 to 90 minutes. The drug effects persist for about one hour. If necessary, the effects of the drug can be abolished promptly by atropine [see OVERDOSAGE ] .

Warnings & Precautions
No warnings available yet.
Contraindications

Hypersensitivity to bethanechol chloride tablets, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. Bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia.

Adverse Reactions

Adverse reactions are rare following oral administration of bethanechol chloride, but are more common following subcutaneous injection. Adverse reactions are more likely to occur when dosage is increased. The following adverse reactions have been observed: Body as a Whole : malaise; Digestive : abdominal cramps or discomfort, colicky pain, nausea and belching, diarrhea, borborygmi, salivation; Renal : urinary urgency; Nervous System : headache; Cardiovascular : a fall in blood pressure with reflex tachycardia, vasomotor response; Skin : flushing producing a feeling of warmth, sensation of heat about the face, sweating; Respiratory : bronchial constriction, asthmatic attacks; Special Senses : lacrimation, miosis. Causal Relationship Unknown The following adverse reactions have been reported, and a causal relationship to therapy with bethanechol chloride has not been established: Body as a Whole : malaise; Nervous System : seizures.

Drug Interactions

Special care is required if this drug is given to patients receiving ganglion blocking compounds because a critical fall in blood pressure may occur. Usually, severe abdominal symptoms appear before there is such a fall in the blood pressure.

Storage & Handling

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight container as defined in the USP. Keep out of reach of children. Distributed by UPSHER-SMITH LABORATORIES, LLC Maple Grove, MN 55369 Made in Taiwan Revised: 4/2025


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →